Programmed cell death protein blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation in an adolescent patient. Issue 3 (4th October 2021) - Sheikh, Irtiza; Nunez, Cesar; McCall, David; Roth, Michael; Cuglievan, Branko